These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31932414)

  • 1. Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.
    Irvin SR; Weiderpass E; Stanczyk FZ; Brinton LA; Trabert B; Langseth H; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):636-642. PubMed ID: 31932414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
    Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
    J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors.
    Su HI; Sammel MD; Green J; Velders L; Stankiewicz C; Matro J; Freeman EW; Gracia CR; DeMichele A
    Cancer; 2010 Feb; 116(3):592-9. PubMed ID: 19918920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
    Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
    Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
    Robertson DM; Lee CH; Baerwald A
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can Inhibin B Reflect Ovarian Reserve of Healthy Reproductive Age Women Effectively?
    Wen J; Huang K; Du X; Zhang H; Ding T; Zhang C; Ma W; Zhong Y; Qu W; Liu Y; Li Z; Deng S; Luo A; Jin Y; Zhang J; Wang S
    Front Endocrinol (Lausanne); 2021; 12():626534. PubMed ID: 33935966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age.
    Steiner AZ; Pritchard D; Stanczyk FZ; Kesner JS; Meadows JW; Herring AH; Baird DD
    JAMA; 2017 Oct; 318(14):1367-1376. PubMed ID: 29049585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated assays for inhibin B and AMH provide evidence for regular episodic secretion of inhibin B but not AMH in the follicular phase of the normal menstrual cycle.
    Randolph JF; Harlow SD; Helmuth ME; Zheng H; McConnell DS
    Hum Reprod; 2014 Mar; 29(3):592-600. PubMed ID: 24357435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
    Anderson RA; Rosendahl M; Kelsey TW; Cameron DA
    Eur J Cancer; 2013 Nov; 49(16):3404-11. PubMed ID: 23968732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood.
    Laporte S; Couto-Silva AC; Trabado S; Lemaire P; Brailly-Tabard S; Espérou H; Michon J; Baruchel A; Fischer A; Trivin C; Brauner R
    BMC Pediatr; 2011 Feb; 11():20. PubMed ID: 21352536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys.
    Cortes D; Clasen-Linde E; Hutson JM; Li R; Thorup J
    J Pediatr Surg; 2016 Mar; 51(3):475-80. PubMed ID: 26452703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships between ovarian and pituitary hormones in ovulatory menstrual cycles across reproductive age.
    Robertson DM; Hale GE; Jolley D; Fraser IS; Hughes CL; Burger HG
    J Clin Endocrinol Metab; 2009 Jan; 94(1):138-44. PubMed ID: 18854393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of serum anti-Müllerian hormone in the follow-up of ovarian adult-type granulosa cell tumors--A comparative study with inhibin B.
    Färkkilä A; Koskela S; Bryk S; Alfthan H; Bützow R; Leminen A; Puistola U; Tapanainen JS; Heikinheimo M; Anttonen M; Unkila-Kallio L
    Int J Cancer; 2015 Oct; 137(7):1661-71. PubMed ID: 25808251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S; Suharjono H; McGarrigle H; Sathanandan M
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
    Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
    Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.